Breaking News

Trials & Filings in Brief: Dec. 3, 2013

Astellas, Conatus, Durata, Lexicon, Medivation, Sanofi, Synageva

Related CONTENT

Gil Roth12.03.13

Phase II
Lexicon completes IBS-d trial . . . read more

Phase III
Astellas, Medivation begin CRPC enrollment . . . read more

Sanofi posts U300 diabetes results . . . read more

Synageva meets enrollment target in LAL deficiency trial . . . read more

Filings
Astellas fungal treatment gets QIDP status . . . read more

Conatus gets Orphan status for liver treatment . . . read more

Durata submits MAA for dalbavancin . . . read more

Related Searches

Suggested For You

Financial Report: Pfizer

Financial Report: Pfizer

Astellas Names President of Astellas US Technologies

Astellas Names President of Astellas US Technologies

Astellas, Affinivax in Global MAPS Vax Pact

Astellas, Affinivax in Global MAPS Vax Pact

BeiGene Appoints CMO

BeiGene Appoints CMO

Astellas Appoints Oncology Marketing VP

Astellas Appoints Oncology Marketing VP

Astellas Bolsters Executive Team

Astellas Bolsters Executive Team

Astellas, Immunomic in Japanese Vax Pact

Astellas, Immunomic in Japanese Vax Pact

Actavis to acquire Durata Therapeutics

Actavis to acquire Durata Therapeutics

TMC Antibiotic Gets QIDP Status

TMC Antibiotic Gets QIDP Status

Trials & Filings in Brief: Jan. 13, 2014

Trials & Filings in Brief: Jan. 13, 2014

Trials & Filings in Brief: Jan. 7, 2014

Trials & Filings in Brief: Jan. 7, 2014

Sanofi Posts U300 Results

Sanofi Posts U300 Results

Durata Submits MAA for Dalbavancin

Durata Submits MAA for Dalbavancin

Synageva Hits Enrollment Target

Synageva Hits Enrollment Target

Astellas Fungal Treatment Gets QIDP Status

Astellas Fungal Treatment Gets QIDP Status

Related Breaking News

Biologics, Proteins, Vaccines | Breaking News | Chemistry | Drug Development | Industry News | R&D

I-Mab Opens New R&D Lab in San Diego

Strengthens global R&D presence with a new integrated lab and operational site in the rapidly growing San Diego biotech hub.
10.22.21
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances

Waters Corp., Delaware University Enter Bioprocessing Research Pact

Aims to develop new analytical solutions to address significant challenges for bioprocessing and biomanufacturing at Immerse Delaware Lab.
10.21.21
Biologics, Proteins, Vaccines | Breaking News | Trials & Filings

Moderna COVID-19 Vax Booster Authorized Under EUA

For people 65 and older; aged 18 to 64 who are at high risk of severe COVID-19 and for eligible individuals who received a different COVID-19 vaccine.
10.21.21
Biologics, Proteins, Vaccines | Breaking News | Trials & Filings

J&J COVID Vax Booster Authorized Under EUA

For adults 18 and older at least two months following primary vaccination; and for eligible individuals who received a different COVID-19 vaccine.
10.21.21
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Logistics | Supply Chain

Autolomous, Vineti Form Cell and Gene Therapy Supply Chain Pact

To integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management platform to create a seamless delivery pathway.
10.19.21
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Trials & Filings

Valneva COVID Vax Meets Co-primary Endpoints in Phase III Trial

Inactivated, adjuvanted VLA2001 demonstrates superiority against AZD1222 in terms of neutralization antibodies.
10.18.21
Breaking News | Clinical Trials | Preclinical Outsourcing

Evergreen Theragnostics Opens New Mfg. Facility in Springfield, NJ

Newly built 14,000 sq.-ft. facility ready to serve the manufacturing needs of companies developing and commercializing radiopharmaceuticals.
10.18.21
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Laboratory Testing

PTC Therapeutics Opens Gene Therapy Manufacturing Facility in NJ

Hopewell facility is approximately 220,500 sq.-ft. of office, manufacturing and laboratory space.
10.15.21
Breaking News | Clinical Trials | Industry News

Caris, Ono Enter Strategic Molecular Profiling Pact

Will leverage Caris' novel, blood-based cNAS molecular profiling assay across several Ono clinical studies.
10.15.21
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Cellumed and ARTES Sign Development and License Agreement

Accelerate development of GMP-grade production enzymes essential for manufacturing mRNA-based biopharmaceuticals.
10.14.21
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

BioCina Expands into Full-service mRNA CDMO

Takes full control of Pfizer manufacturing facility in Adelaide, Australia.
10.14.21
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Lexeo Therapeutics, Fujifilm Diosynth Biotechnologies Enter Cell & Gene Partnership

Collaboration to enable manufacturing of AAV-mediated gene therapies for LEXEO’s upcoming clinical trials, future IND-enabling studies and commercialization.
10.14.21
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves

Avid Bioservices Expands CDMO Offerings into Cell and Gene Therapy Market

Appoints Drew Brennan as general manager of viral vector technologies to lead the expansion.
10.14.21
Breaking News | Clinical Trials | CRO News

ObsEva, Syneos Health Partner to Commercialize Linzagolix

Linzagolix, an oral GnRH antagonist, is pending regulatory approval in the U.S. and Europe for the treatment of uterine fibroids.
10.13.21
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

MilliporeSigma Opens Second Facility in Carlsbad

More than doubles the company’s existing capacity to support large-scale commercial and industrial manufacturing for viral gene therapy.
10.13.21